Volume: 27 Issue: 12

1. Research progress of dead-in-bed syndrome in type 1 diabetes Page:1032—1035
2. Approach to the patient with parathyroid adenoma and thyroid remnant goiter Page:1025—1027
3. Serum level of 25-dihydroxyvitamin D3 in patients with diabetic nephropathy Page:1002—1003
4. Analysis of basic research in endocrine and metabolic projects granted by National Natural Science Foundation of China Page:1017—1020
5. Approach to the patients with Gitelman syndrome Page:1028—1031
6. Pharmacoeconomics of the oral antidiabetic drugs in National Essential Medicine Page:1021—1024
7. Effect of sex hormones on secretions of leptin and adiponectin by adipocytes Page:1009—1012
8. Expression and significance of cytokeratin-19, vimentin, vascular endothelial growth factor-C, and cyclooxygenase-2 in Graves' disease and Hashimoto's thyroiditis Page:983—987
9. Cognitive impairment caused by primary hypothyroidism Page:979—982
10. Factors related to the therapeutic efficacy of 131 Ⅰ in Graves' disease Page:975—978
11. Relationship between iodine intake and the prevalence of thyroid disease in Urumqi, Xinjiang Page:972—974
12. Inducing differentiation of human amnion-derived mesenchymal stem cells into insulin-secreting cells in vitro Page:1013—1016
13. Effects of FGF-21 gene knockdown on glucose and lipid metabolism in ApoE-/- mice Page:1004—1008
14. Acute glucagon response associated with the long-term remission of newly-diagnosed type 2 diabetes Page:992—995
15. A survey of the prevalence of diabetes mellitus in adults of Zhejiang province Page:988—991
16. Association of HLA-DRB1 allele polymorphism and ANCA with the susceptibility to antithyroid drug-induced leucocytopenia in patients with Graves' disease Page:967—971
17. Recent progress in identification of candidate genes of Graves' disease Page:961—966
18. Efficacy and safety of vildagliptin and metformin combination therapy in type 2 diabetes Page:后插1—后插4